Trump’s GLP-1 Price Cut Shakes Lilly Novo Stocks

Imagine paying just $150 for blockbuster weight loss drugs that currently cost over $1,000. Trump's latest comments sent Eli Lilly...

17/10/2025

0 views

Eli Lilly’s Obesity Pill: A Game-Changer for Health

Eli Lilly's new obesity pill could change lives with impressive weight loss and diabetes control. But what makes it stand...

26/08/2025

2 views

Eli Lilly’s new obesity pill could shake up the weight loss market, rivaling Novo Nordisk’s oral Wegovy. But what makes...

24/08/2025

2 views

Novo Nordisk’s shares tanked after a slashed forecast. Compounded GLP-1 drugs are eating into Wegovy’s market. Is this a dip...

29/07/2025

2 views

A new Chinese obesity drug shows stunning results, rivaling Zepbound. Could this reshape the weight loss market? Click to find...

16/07/2025

2 views

Novo Nordisk slashes its 2025 forecast but surges 6.5% as it vows to crush copycat obesity drugs. Will Wegovy reclaim...

07/05/2025

0 views